key: cord-0735568-4lcbtxjd
authors: Biquard, Louise; Valla, Dominique; Rautou, Pierre-Emmanuel
title: No evidence for an increased liver uptake of SARS-CoV-2 in metabolic associated fatty liver disease
date: 2020-04-30
journal: J Hepatol
DOI: 10.1016/j.jhep.2020.04.035
sha: 7e8472520ff77977f27f9fa3935e4ed430079016
doc_id: 735568
cord_uid: 4lcbtxjd

nan

Louise BIQUARD 1 , Dominique VALLA 1,2,3 , Pierre-Emmanuel RAUTOU 1 with biopsy proven NASH. Using these datasets, we observed that none of the genes necessary for SARS-CoV-2 infection was differentially expressed between lean or obese controls and patients with simple steatosis or with NASH (Table 1) .

We performed the same analysis in a mouse dataset published by Xiong and colleagues 7 on whole liver RNA-Seq of mice subjected to 36 weeks high fat diet. Similarly, we observed no increase in liver gene expression of the four proteins implicated in SARS-CoV-2 infection between mice with MAFLD mice and control mice (data not shown).

In conclusion, MAFLD is not associated with changes in liver expression of genes implicated in SARS-CoV-2 infection. The observed persistence of liver blood test abnormalities reported by Ji and colleagues is thus likely not explained by an increased liver SARS-CoV-2 uptake. 

Implication of nonalcoholic fatty liver diseases (NAFLD)

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct diseasespecific and remodeling signatures after bariatric surgery

Human liver biopsy of different phases from control to NASH

Mapping the molecular signatures of diet-induced NASH and its regulation by the hepatokine Tsukushi